The exponential rise in digital content has made Automatic Text Summarization (ATS) an indispensable tool in information retrieval and knowledge management. Neural network architectures have significantly advanced the eficiency and accuracy of ATS systems, particularly in specialized domains requiring precise and reliable information synthesis. This paper provides a comprehensive review of recent advancements in neural network-based summarization models, highlighting the state-of-the-art methodologies, challenges faced in adapting these models to complex, domain-specific texts, and areas for future research. Additionally, the limitations of current techniques are critically analyzed, alongside the emerging need for more robust evaluation metrics to ensure the practical relevance and efectiveness of ATS systems. This work aims to provide valuable insights to researchers and practitioners dedicated to advancing the capabilities of ATS technologies.
The explosive growth of digital data presents significant challenges in managing, retrieving, and synthesizing relevant information eficiently. In response, ATS has emerged as a indispensable tool for distilling large volumes of text into concise, meaningful summaries. By providing users with simplified representations of complex content, ATS systems can greatly enhance information accessibility and utility. However, the complexity and domain-specific nature of certain texts, especially in technical fields, create a demand for more sophisticated summarization techniques.
Recent advancements in neural network architectures, particularly deep learning models such as recurrent neural networks, transformers and generative AI, have revolutionized the field of ATS. These models, which leverage techniques such as attention mechanisms and pre-training on large corpora, have demonstrated substantial improvements over traditional rule-based or statistical methods. By enabling more context-aware and coherent summaries, neural networks have set new standards for both extractive and abstractive summarization tasks.
Despite these advancements, numerous challenges remain. Neural network models, while powerful, often struggle with domain-specific content where terminological precision and factual consistency are critical. This is particularly evident in fields where summarization tasks must meet high standards of accuracy and reliability. Moreover, the inherent complexity of neural networks makes them prone to issues like overfitting and generalization errors, especially when applied to specialized corpora. These limitations call for further research into more robust, adaptable architectures that can handle the intricacies of complex textual data.
As the field continues to evolve, there is also a growing need for more comprehensive evaluation metrics that go beyond surface-level text matching. While metrics like ROUGE and BLEU have been widely adopted, they are often inadequate for assessing the deeper semantic accuracy required in domain-specific summarization. Consequently, developing new metrics that better capture the relevance, accuracy, and completeness of summaries will be crucial for advancing the efectiveness of ATS systems in specialized applications.
In recent years, the volume of clinical data has increased exponentially, creating a need for
eficient methods to distill key information from complex medical texts [
Recent advancements in neural networks have significantly impacted the field of text
summarization. Sequence-to-sequence (Seq2Seq) models, transformers, BERT, and GPT are among the
most prominent models used for this purpose. Seq2Seq models, particularly those enhanced
with attention mechanisms, have shown substantial improvements in generating coherent
summaries [
In the medical domain, these models have been adapted to handle the unique challenges posed
by clinical texts. For instance, BERT-based models have been employed to classify and summarize
clinical reports, achieving high accuracy in identifying key findings from radiographic reports
[
Clinical text summarization faces several unique challenges, including the complexity of medical
jargon, the presence of regulatory language, and the sensitivity of information. Medical texts
often contain specialized terminology that can be dificult for general models to understand and
accurately summarize [
Current models, while advanced, still face limitations such as generalization and overfitting.
For example, BERT’s performance can be inhibited by its pretraining and tokenization methods,
which may not be well-suited for the specific nuances of clinical texts [
Explainable AI (XAI) refers to the development of machine learning models that provide transparent, understandable, and interpretable explanations for their decisions and predictions. In clinical decision support, XAI plays a critical role by ofering insights into the reasoning behind AI-driven recommendations, making them more accessible and trustworthy for healthcare professionals. The ability to interpret AI models’ outputs is particularly important in healthcare, where decisions can directly impact patient outcomes. This section explores the application of XAI in clinical decision support systems (CDSS) and its potential to enhance decision-making processes in healthcare settings.
XAI techniques are increasingly being applied to clinical decision support systems to enhance
the interpretability of AI models [
XAI is also crucial for diagnostic decision support[
Another area where XAI plays a critical role is in clinical text summarization[
Several XAI techniques, such as SHAP (SHapley Additive exPlanations) and LIME (Local
Interpretable Model-agnostic Explanations), have been developed to provide transparency in
clinical decision-making and enhance the interpretability of AI models. SHAP and LIME are
model-agnostic approaches that explain individual predictions by quantifying the contribution
of each feature. In healthcare, these techniques can be used to explain risk scores or diagnosis
predictions based on patient data. For example, SHAP can show how a patient’s age, blood
pressure, and previous medical history contribute to a prediction of heart disease risk, while
LIME can generate interpretable explanations for specific predictions by approximating the
model locally. Attention mechanisms, often used in deep learning models, highlight which
parts of the input data (e.g., text or images) are most important for a prediction. In clinical
settings, attention mechanisms can be applied to models processing medical texts or images to
pinpoint key features influencing decisions, providing clinicians with a visual representation of
the model’s focus areas. Additionally, counterfactual explanations ofer insights by showing
how changes in input data would lead to diferent model outcomes. In clinical decision support,
counterfactuals can demonstrate how modifying a patient’s treatment plan or clinical data would
afect the risk prediction or diagnostic outcome, helping clinicians understand the potential
impact of various decisions. These techniques, applied to NLP models, are crucial in enhancing
the transparency of AI-driven decision-making in healthcare, fostering trust and better decision
support for clinicians [
Despite the significant progress in the development of neural network models for clinical text summarization, there remain notable gaps in explainability that hinder the full adoption and trust of these models in clinical settings. One of the primary challenges is the "black-box" nature of many advanced neural network models, which makes it dificult for clinicians to understand how the model generates summaries or selects key information. This lack of transparency can undermine the reliability of AI systems, especially in critical clinical contexts where errors can have serious consequences.
A key gap is the limited interpretability of attention mechanisms, which are widely used in models like transformers for summarization tasks. While attention mechanisms can identify which parts of the text are most influential in generating a summary, they do not provide a clear rationale for why certain sections were prioritized over others. For example, a model may highlight specific symptoms or treatments in a summary, but without a deeper explanation, it remains unclear whether the model is making decisions based on medical relevance, statistical patterns, or other factors. This opacity can lead to confusion and reduce clinician confidence in the system’s recommendations.
Additionally, current techniques for model interpretation often struggle to account for the complex and context-dependent nature of medical texts. Clinical documents, such as patient histories and discharge summaries, contain nuanced information that can be influenced by a variety of factors, including the patient’s unique medical history, current health status, and environmental factors. Neural networks may aggregate these data points in ways that are not always intuitive, and existing interpretability methods may fail to capture the full context of the decision-making process.
Furthermore, while models such as BERT and GPT have demonstrated strong performance in generating clinical summaries, the explanations of these models often do not align with human reasoning. Clinicians may struggle to relate the model’s output to their own diagnostic process, which is typically based on years of training and clinical experience. The mismatch between AI-generated summaries and clinical intuition can create barriers to efective collaboration between AI systems and healthcare professionals.
Finally, the absence of standardized frameworks for evaluating the explainability of clinical text summarization models contributes to the gap in understanding. Without clear metrics or guidelines for assessing the transparency of these models, it is dificult for researchers and clinicians to gauge the efectiveness of XAI techniques or to compare diferent models across studies.
Addressing these gaps is crucial for improving the trustworthiness and efectiveness of neural network-based clinical text summarization systems. By developing more interpretable models, enhancing the transparency of decision-making processes, and aligning AI outputs with human reasoning, researchers can create more reliable and user-friendly tools for clinicians.
The efectiveness of neural network models in automatic text summarization is determined not
only by their ability to generate coherent and concise summaries but also by how well they
capture essential information from the source text. In the clinical domain, the accuracy and
relevance of the generated summaries are paramount, given the complexity and sensitivity of
medical data [
In this section, we explore various methods for evaluating summarization models, including
widely adopted metrics in general text summarization, as well as specialized metrics tailored
to the clinical domain. Additionally, with the growing emphasis on explainable AI (XAI), we
discuss metrics that assess the interpretability and transparency of model outputs, which are
critical for the practical use of AI systems in healthcare [
The evaluation of neural networks in automatic text summarization is a crucial component in determining the efectiveness of models across diferent tasks. Both qualitative and quantitative metrics are used to assess how well a model captures the salient points of the source text and generates coherent, accurate summaries. In the context of clinical text summarization, where precision and information retention are paramount, robust evaluation metrics are essential for validating the performance of these models.
Several standard metrics are employed to evaluate text summarization models, most notably:
• ROUGE (Recall-Oriented Understudy for Gisting Evaluation): ROUGE is one of
the most widely used metrics in text summarization, especially for extractive methods. It
measures the overlap between the generated summary and reference summaries, primarily
focusing on n-grams, word sequences, and word pairs [
In clinical summarization, accuracy and relevance of the information retained in summaries are
critical. Therefore, in addition to the aforementioned metrics, several domain-specific evaluation
methods are utilized:
• Precision and Recall: These metrics are particularly important in clinical
summarization, where false positives (irrelevant information) and false negatives (missing key
clinical details) can have serious consequences. Precision evaluates the relevance of the
information included, while recall assesses the completeness of the summary [
With the increasing demand for explainable AI (XAI) in healthcare, new metrics are being
developed to evaluate the transparency and interpretability of neural network models. Some
emerging metrics include:
• SHAP (SHapley Additive exPlanations): SHAP values provide insight into the
contributions of individual features or words in a model’s decision-making process, allowing
healthcare professionals to understand why certain text segments were included or
omitted in the summary [
While existing metrics provide valuable insights into model performance, there are still challenges in evaluating text summarization models, particularly in the clinical domain. For instance, most automated metrics like ROUGE and BLEU do not adequately capture semantic accuracy or the clinical importance of information. Moreover, the subjective nature of clinical relevance often requires expert validation, which can be resource-intensive. Additionally, the increasing complexity of neural network models makes explainability a growing concern, as traditional metrics do not account for the interpretability of model decisions. Therefore, future evaluation eforts should focus on developing more comprehensive metrics that combine automated evaluation with expert review, while also incorporating transparency and interpretability measures to ensure the clinical viability of summarization systems.
The studies reviewed demonstrate significant advances in the automatic summarization of
clinical trial data, both for extractive and abstractive methods. The TextRank algorithm
performed well for extractive summarization tasks, ofering concise, meaning-preserving synopses
of clinical trial descriptions. Similarly, ontological and domain-specific models, such as those
incorporating BERTSUMEXT and other neural models, have demonstrated improvements in
abstractive summarization, as seen in [
A key advantage in this domain is the use of neural architectures, particularly transformers and pre-trained models, to address the challenges of clinical text summarization. In particular,it achieved strong results with multi-objective optimization techniques, leveraging sentence position and similarity metrics like: Term Frequency-Inverse Document Frequency (TF-IDF ) and Word Mover’s Distance (WMD). These methods not only outperform human gold standard summaries in some cases but also ofer practical utility in new disease settings, such as during the emergence of novel diseases like COVID-19.
One common challenge noted in many papers was the tendency of abstractive models to introduce factual inaccuracies, particularly when summarizing biomedical evidence across multiple documents.
While the advancements in automatic summarization are promising, there remain significant limitations. First, the lack of transparency and controllability in many neural models limits their practical utility in medical settings. Although systems like TrialsSummarizer aim to enhance user verification by allowing traceability of generated tokens, more work is needed to ensure end-users can reliably trust the outputs.
Another critical limitation lies in the evaluation methods for summarization quality. The heavy reliance on ROUGE scores is not always aligned with the preferences of healthcare professionals. This gap between automatic and manual evaluations highlights the need for more domain-specific evaluation metrics that better reflect clinical relevance and accuracy. Moreover, inter-rater agreement among human evaluators often varies.
Looking ahead, the integration of Explainable AI (XAI) approaches holds great potential for
improving the transparency and usability of clinical summarization models. For instance,
enhancing the traceability of neural model outputs—where users can see which portions of the
input data contribute to each generated sentence—could improve trust in automated summaries.
Additionally, further fine-tuning models with clinical-specific ontologies (e.g., UMLS) could
improve both the factual accuracy and content relevance of generated summaries, as demonstrated
in [
Another promising direction is the exploration of multi-document summarization systems that can handle vast datasets, such as those found on ClinicalTrials.gov. For instance, the EXACT system shows that automated extraction can drastically reduce the time needed to summarize and analyze clinical trial data for meta-analyses.
Lastly, improving factual verification mechanisms within neural models should be prioritized, as this will be crucial for the real-world deployment of such systems in clinical decision-making contexts. Collaborating with medical professionals to ensure practical utility and relevance will be key in advancing from experimental models to operational clinical tools.
This paper has provided an in-depth exploration of the role of ATS in clinical applications, particularly within the context of neural network-based models. We reviewed the key advancements in these models, emphasizing their potential to enhance clinical decision-making processes by improving the eficiency and accuracy of summarizing complex medical texts. Despite the significant progress made, several challenges remain, including the adaptation of neural networks to the specific demands of the healthcare domain and the need for greater transparency in the decision-making process.
The paper also highlighted the growing importance of Explainable AI (XAI) in clinical decision support. By incorporating XAI techniques, such as SHAP, LIME, and attention mechanisms, into clinical text summarization, AI systems can provide valuable insights into their predictions, fostering trust and aiding clinicians in making informed decisions. However, the gap in explainability for neural networks, particularly in clinical text summarization, persists and demands further investigation. Furthermore, we discussed the current limitations of existing evaluation metrics and the need for domain-specific measures that better capture the nuances of clinical text summarization. As medical data becomes more complex, the development of robust evaluation frameworks will be critical to ensuring that ATS systems deliver high-quality, clinically relevant summaries.
In conclusion, while there is great potential for neural network-based ATS systems in clinical settings, future research must address the challenges related to model explainability, evaluation metrics, and the practical application of these technologies. By doing so, we can further enhance the efectiveness of ATS systems and support clinicians in delivering optimal patient care.
During the preparation of this work, the authors used the free version of ChatGPT for grammar and spelling checks, as well as for some reformulations to improve readability.
After using this tool, the authors reviewed and edited the content as needed and take full responsibility for the publication’s content, in accordance with the for the publication’s content.